Works matching DE "CORIXA Corp."
Results: 5
Lymphoma market turf war imminent, pending Bexxar approval.
- Published in:
- Nature Biotechnology, 2003, v. 21, n. 2, p. 115, doi. 10.1038/nbt0203-115
- By:
- Publication type:
- Article
Corixa buys Coulter.
- Published in:
- Nature Biotechnology, 2000, v. 18, n. 12, p. 1230, doi. 10.1038/82277
- By:
- Publication type:
- Article
Cancer vaccine deal.
- Published in:
- Nature Biotechnology, 1999, v. 17, n. 8, p. 735, doi. 10.1038/11620
- By:
- Publication type:
- Article
Iodine-131 Tositumomab: 131I-anti-B1 antibody, 131I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar™, 131I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
- Published in:
- BioDrugs, 2003, v. 17, n. 4, p. 290
- By:
- Publication type:
- Article
Mergers/Acquisitions.
- Published in:
- Applied Clinical Trials, 2005, v. 14, n. 9, p. 68
- Publication type:
- Article